In the present study, we evaluated the protective efficacy of the rPspA-PlD1 fusion protein against pneumococcal pneumonia, using a mouse model of focal pneumonia–which mimics the clinical features of lung colonization by pneumococci and reflects the natural course of human infections. Here, PLD1 is linked to infection.